| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2021 | Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern | Lien, CE; Kuo, TY; Lin, YJ; Lian, WC; Lin, MY; Liu, LTC; Chou, YC ; Chen, C | MedRxiv | | | |
| 2021 | Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern | Lien, CE; Kuo, TY; Lin, YJ; Lian, WC; Lin, MY; Liu, LT; Cheng, J; Chou, YC ; Chen, C | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(11), 1899-1905 | | | |
| 2021 | Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan | Hsieh, SM; Liu, MC; Chen, YH; Lee, WS; Hwang, SJ; Cheng, SH; Ko, WC; Hwang, KP; Wang, NC; Lee, YL; Lin, YL ; Shih, SR; Huang, CG; Liao, CC ; Liang, JJ; Chang, CS; Chen, C; Lien, CE; Tai, IC; Lin, TY | The Lancet. Respiratory medicine 9(12), 1396-1406 | | | |
